Pancreatic Cancer Research

Clinical trialNARecruiting

Liquid Biopsy and Pancreas Cancer: Detection of AXL(+) CTCs (CTC-AXL-PANC)

Liquid Biopsy and Pancreas Cancer: Detection of AXL(+) Functional CTCs Using EPIDROP

NCT05346536↗ ClinicalTrials.gov, retrieved 4 November 2026

Outcome
Ongoing
Phase
NA
Status
Recruiting
Study type
Interventional
Start
16 June 2022
Expected end
31 December 2027
Enrollment
63 participants
Sites
1
Primary outcomes
CTC-AXL measurement concordance rate
Sponsor
Other
Results posted
No
Last update
22 June 2026

These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.

Try

Papers 7